1. "Individualized assessment of preterm birth risk using two modified prediction models" from M. Mailath-Pokorny and colleagues. (May 2015) Authors: Vivanti, A.J.; Benachi, A.; Rouzier, R. Journal: European journal of obstetrics, gynecology, and reproductive biology Issue: Volume 188(2015:May) Page Start: 136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 177 Associated lichen sclerosis increases the risk of lymph node metastases of vulvar cancer. (September 2015) Authors: Gosset, M.; Bastuji-Garin, S.; Wylomanski, S.; Plantier, F.; Ballester, M.; Daraï, E.; Paniel, B.J.; Haddad, B.; Rouzier, R.; Touboul, C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2740 Independent review committee assessment of Fagotti carcinomatosis score from 8 laparoscopic images: Ancillary analysis of ANTHALYA, a randomized, open-label, phase II study assessing the efficacy and safety of bevacizumab addition to neoadjuvant therapy for women with ovarian, tubal or peritoneal adenocarcinoma, initially unresectable. (September 2015) Authors: Chéreau, E.; Gouy, S.; Lambaudie, E.; Ballester, M.; Fourchotte, V.; Guyon, F.; Pomel, C.; Colombo, P.E.; Delroeux, D.; Martin-Francoise, S.; Bihan, C.; Leblanc, E.; Lecuru, F.; Fouche, Y.; Ghazi, Y.; Pau, D.; Selle, F.; Cottu, P.; Joly, F.; Rouzier, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S543 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2766 Safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Data from the ANTHALYA trial. (September 2015) Authors: Selle, F.; Gouy, S.; Lambaudie, E.; Guyon, F.; Fourchotte, V.; Pomel, C.; Colombo, P.E.; Kalbacher, E.; Martin-Francoise, S.; Fauvet, R.; Follana, P.; Lesoin, A.; Lecuru, F.; Menguy, V.; Ghazi, Y.; Chereau, E.; Zohar, S.; Cottu, P.; Joly, F.; Rouzier, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 5-year overall survival after early breast cancer diagnosed during pregnancy: A retrospective case-control multicentre French study. (May 2018) Authors: Ploquin, A.; Pistilli, B.; Tresch, E.; Frenel, J.S.; Lerebours, F.; Lesur, A.; Loustalot, C.; Bachelot, T.; Provansal, M.; Ferrero, J.M.; Coussy, F.; Debled, M.; Kerbrat, P.; Vinceneux, A.; Allouache, D.; Morvan, F.; Dalenc, F.; Guiu, S.; Rouzier, R.; Vanlemmens, L. Journal: European journal of cancer Issue: Volume 95(2018) Page Start: 30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Association of the number of sentinel lymph nodes harvested with survival in breast cancer. Issue 1 (January 2015) Authors: Bonneau, C.; Bendifallah, S.; Reyal, F.; Rossi, L.; Rouzier, R. Journal: European journal of surgical oncology Issue: Volume 41:Issue 1(2015:Jan.) Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Association with pregnancy increases the risk of local recurrence but does not impact overall survival in breast cancer: A case–control study of 87 cases. (December 2016) Authors: Genin, A.S.; De Rycke, Y.; Stevens, D.; Donnadieu, A.; Langer, A.; Rouzier, R.; Lerebours, F. Journal: Breast Issue: Volume 30(2016) Page Start: 222 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis. (November 2022) Authors: Curtit, E.; Bellanger, M.; Nerich, V.; Hequet, D.; Frenel, J.S.; Cristeau, O.; Rouzier, R. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes. Issue 8 (August 2015) Authors: Bonneau, C.; Hequet, D.; Estevez, J.P.; Pouget, N.; Rouzier, R. Journal: European journal of surgical oncology Issue: Volume 41:Issue 8(2015:Aug.) Page Start: 998 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Impact of completion axillary lymph node dissection in patients with breast cancer and isolated tumour cells or micrometastases in sentinel nodes. (November 2016) Authors: Houvenaeghel, G.; Boher, J.M.; Reyal, F.; Cohen, M.; Garbay, J.R.; Classe, J.M.; Rouzier, R.; Giard, S.; Faure, C.; Charitansky, H.; Tunon de Lara, C.; Daraï, E.; Hudry, D.; Azuar, P.; Gimbergues, P.; Villet, R.; Sfumato, P.; Lambaudie, E. Journal: European journal of cancer Issue: Volume 67(2016) Page Start: 106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗